Taevas
United StatesMedical Devices
Product Registration
Product Registration for Medical Devices in United States
Taevas Global helps medical devices manufacturers navigate FDA registration requirements, select the right regulatory pathway, and achieve market clearance in the United States with speed and confidence. Whether you are entering for the first time or expa
Market
United States
Industry
Medical Devices
Service
Product Registration
Regulator
FDA Center for Devices and Radiological Health (CDRH)
Timeline
3 to 12+ months depending on device class
What We Deliver
Six Pillars of United States Medical Devices Intelligence
Our six interconnected pillars give medical devices companies a complete regulatory and commercial foundation for successful product registration in the United States.
01
Device Classification and Pathway Selection
Correctly classifying your device under FDA's Class I, II, or III framework is the single most consequential decision in the registration process. We analyze your device's intended use, technological characteristics, and predicate landscape to identify the optimal pathway — 510(k), De Novo, or PMA — before a single document is drafted. Getting this right at the outset prevents costly reclassification or submission rejection later.
FDA product code and classification database analysis
Predicate device identification for 510(k) submissions
Risk-based pathway comparison: 510(k) vs De Novo vs PMA
How It Works
From Brief to Board-Ready Intelligence
Our four-stage engagement takes you from initial device assessment through a complete, submission-ready registration package delivered with full expert support.
Step 1 · Day 1-2
Discovery and Device Assessment
We begin with a structured intake session to understand your device's intended use, technological features, target patient population, and commercial objectives. Our regulatory experts review existing technical files, clinical data, and quality system documentation to establish a baseline. This discovery phase produces a clear scope of work and an initial risk assessment.
Taevas Approach
During discovery, we collect your device description, intended use statement, existing test reports, predicate device candidates if identified, and any prior FDA correspondence. We use FDA's product classification database and 510(k) predicate search tools to conduct a preliminary classification analysis. The output is a Discovery Summary Memo that confirms the regulatory pathway recommendation and identifies documentation gaps before any billable work begins on submission preparation.
Market Snapshot
United States Medical Devices Market at a Glance
$0B
U.S. Medical Devices Market Size (2024)
0%
Projected Annual Market Growth Rate
0+
FDA-Registered Device Manufacturers
0+
510(k) Decisions Issued Annually by FDA
World's Largest Single Medical Devices Market
The United States accounts for approximately 40 percent of global medical devices sales, making it the single most valuable market for any device manufacturer. The combination of high per-capita healthcare spending, advanced hospital infrastructure, and strong reimbursement frameworks drives sustained demand across all device categories. Gaining FDA clearance or approval unlocks access to over 6,500 hospitals and a vast network of ambulatory surgical centers and outpatient clinics.
FDA CDRH: The World's Most Scrutinized Regulator
FDA's Center for Devices and Radiological Health (CDRH) sets the global benchmark for device safety and effectiveness review, and clearance by FDA carries significant credibility in other markets. The 510(k) pathway remains the most common route to market, accounting for over 80 percent of annual premarket submissions, but FDA has increased its scrutiny of substantial equivalence arguments and performance data. Companies that invest in rigorous pre-submission preparation consistently achieve faster review cycles and fewer Additional Information requests.
Digital Health and AI Devices Are Reshaping Registration
Software as a Medical Device (SaMD), AI-enabled diagnostics, and connected health platforms represent the fastest-growing device categories in the United States, and FDA has issued a series of new guidance documents specifically addressing these technologies. The FDA's Digital Health Center of Excellence and the predetermined change control plan framework for AI/ML devices are creating new registration pathways that did not exist five years ago. Manufacturers of digital health products must navigate both traditional device classification rules and evolving software-specific requirements simultaneously.
Supply Chain and Manufacturing Compliance Under Scrutiny
FDA's Quality System Regulation under 21 CFR Part 820 is being updated to align with ISO 13485:2016 through the Quality Management System Regulation (QMSR) final rule, which takes effect in February 2026. Manufacturers with ISO 13485 certification will have a compliance advantage, but gaps between ISO requirements and FDA-specific obligations such as complaint handling and MDR reporting still require careful management. Foreign manufacturers exporting to the United States must also maintain a U.S. Agent and comply with FDA import requirements enforced at the border.
What's Included
Everything in Your Report
Each Product Registration engagement for Medical Devices in the United States delivers a comprehensive set of documents, analyses, and strategic assets your team can act on immediately.
Device Classification and Pathway Report
A formal written analysis confirming your device's FDA product code, classification, and recommended regulatory pathway with supporting rationale drawn from FDA databases and guidance documents.
Complete Premarket Submission Package
A fully drafted and quality-reviewed 510(k) premarket notification, De Novo request, or PMA application compiled in FDA eCopy format and ready for electronic submission through FDA's eSubmitter portal.
Predicate Device Analysis
A detailed comparison of your device against identified predicate devices, documenting substantial equivalence in intended use and technological characteristics with supporting evidence to satisfy FDA reviewer expectations.
Regulatory Gap Analysis and Compliance Checklist
A section-by-section gap assessment mapping your existing technical documentation against FDA submission requirements, with a prioritized action list for closing identified gaps before filing.
Labeling and IFU Package
Compliant device labeling, Instructions for Use, and packaging text drafted to meet 21 CFR Part 801 requirements, including UDI carrier placement and GUDID submission data.
Establishment Registration and Device Listing Filing
Completed FDA establishment registration through the FURLS system and device listing submission under 21 CFR Part 807, including U.S. Agent designation documentation for foreign manufacturers.
FDA Correspondence and AI Request Management
Full management of all FDA reviewer correspondence during the submission review period, including drafting and filing responses to Additional Information requests within FDA's required response windows.
Post-Clearance Compliance Roadmap
A structured post-clearance action plan covering MDR reporting program setup, annual registration renewal schedule, UDI database maintenance, and a change assessment framework for future device modifications.
Who This Is For
Built for These Situations
Market Entry
Foreign Manufacturer Entering the U.S. Market
You manufacture medical devices outside the United States and are ready to access the world's largest healthcare market but have limited experience with FDA's regulatory framework. Your team understands your device's clinical value but needs expert guidance on device classification, the 510(k) or PMA pathway, U.S. Agent requirements, and establishment registration. Every month of delay costs you commercial opportunity in a market where competitors are already cleared.
Outcome
Achieve FDA clearance or approval through a structured, expert-managed process that minimizes submission deficiencies and accelerates your U.S. market entry timeline.
Next Steps
After Product Registration, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your United States Opportunity?
Taevas Global's medical devices regulatory team is ready to assess your device, define your FDA registration strategy, and manage your submission from first draft to clearance. Contact us today to begin your U.S. market entry with confidence.
Expert FDA regulatory strategy tailored to your device class and pathway
End-to-end submission preparation, filing, and FDA correspondence management
Post-clearance compliance roadmap covering MDR, UDI, and annual registration
Dedicated regulatory affairs specialists with deep U.S. medical devices experience